About CACO-SF Bay Area Workshops:

 

We organize frequent workshops on various topics in drug discovery and development and provide these workshops as a minimum-cost service to scientists in the biotech and pharmaceutical industries.  Members who are between jobs are allowed to attend the workshops paying only for the cost of the handouts. These workshops are always well attended, attracting approximately 150 attendees per workshop.  Each workshop is like a short course in one afternoon, covering both the fundamentals and applications of the topic in drug discovery and development. Our speakers are highly regarded, experienced scientists mostly from the biotech and pharmaceutical industries.

 

Areas of workshop topics:

  • Drug metabolism and pharmacokinetics

  • Analytical chemistry / mass spectrometry

  • Pharmaceutical development

  • Preclinical studies

To suggest a workshop topic and / or a speakers, click here to contact our programs chair.

 

Instructions for speakers:  click here.

 

Workshop Details & Registration: www.caco-ca.org (click on the name of each workshop and the names of the speakers for details)

 

Upcoming Workshops

 

Workshop Name  Speakers Date Major Sponsor
Modern NMR technologies for trace compound analysis: metabolites, impurities, and degradants Joe Pease (Roche), Raju Subramanian (Amgen), Smriti Khera (Amgen) 05/14/2010 XenoBiotic Laboratories
Solid Dosage Forms: Theory, Formulation Strategies & Case Studies for Clinical Developments  (co-organized with University of the Pacific) B.R. Jasti, X. Li, R. Nyshadham, R. Mahalingam 06/10/2010  
PK Modeling Harvey Wong, PhD (Genentech); Matt Wright, PhD (Gilead); Natilie Hosea, PhD (Pfizer); Jane Kenny Genentech) 08/02/2010 BD Biosciences
Statistics fundamentals   2010  
Species differences and the impact on DMPK properties   2010  
Case studies: trouble-shooting high clerarance and poor bioavailability   2010  
Excel for Scientists   2010  
Preclinical Mass Balance and Metabolite Profiling Studies   2010  
Human ADME Studies: Mass Balance and Metabolite Profiling   2010  

 

 

Previous Workshops

 

Workshop Name  Speakers Date Major Sponsor
Drug Transporters: Interpretation and Application of the International Transporter Consortium Whitepaper and Draft FDA Guidance Joseph Polli (GSK), Caroline Lee (Pfizer), Harma Ellens (GSK), Xiaoyan Chu (Merck) 04/19/2010 Qualyst, Inc.
ADME Sciences as Applied to Assessing Safety Testing (MIST) Scott Obach (Pfizer) 03/10/2010 XenoBiotic Laboratories
Non-clinical Drug Safety and Toxicology: From Discovery to Market with Large Molecule Drugs Ben Marafino, Jr. (SMC),
Kathleen Meyer (XOMA)		 02/22/2010 Pacific Biolabs
Introductory LC/MS Jack Henion 01/12/2010 Agilent Technologies
Advanced LC/MS Practices Jack Henion 01/13/2010 Alturas Analytics; BASi
Advances in Analytical and Automation Technologies for DMPK Patrick Rudewicz (Genentech), Jane Huang (Roche), Ji Ma (Amgen), Sheerin Shahidi (Genentech), John Laycock (Amgen) 12/8/2009 Advanced Chemistry Development, Inc., (ACD/Labs)
Non-clinical Drug Safety and Toxicology: From Discovery to Market with Small Molecule Drugs Ben Marafino, Jr. (SMC),
Kathleen Meyer (XOMA)		 10/26/2009 Pacific BioLabs
Dug metabolite identification Bill Fitch (Roche), Shichang Miao (ChemoCentryx), Deepak Dalvie (Pfizer) 9/30/2009 Thermo
Clinical Pharmacokinetics & Pharmacodynamics in Drug Development Graham Jang (Amgen), David Lau (Rigel), Nelson “Shasha” Jumbe (Roche) 9/8/2009 Applied Biosystems
DMPK and Clinical Pharmacology Studies in IND and NDA Submissions: Leveraging Regulation and Science in Clinical Drug Development and Regulatory Decisions Derek Zhang (Frontage Laboratories), Deanna Kroetz (UCSF) 8/17/2009 Cyprotex
Pharmacokinetic profiles for large molecules  Suhasini Iyer (Genentech), Jay Tibbitts (Genentech), Valerie Quarmby (Genentech) 4/28/2009 Tandem Labs
HPLC for DMPK, Bioanalysis, and Analytical Development: Liquid Chromatography Essentials, Best Practices, and Recent Developments.  Michael Dong; Patrick Rudewicz (Genentech) 3/26/2009 Alturas
Preclinical Development & IND filing Tracy Chen (Depomed), Linval Depass (Duret), Jeff Etter (Celegen), Jim Wei (Medpace) 2/26/2009 Absorption Systems, BD, Avantium
Physicochemical properties and Preformulation Support for PK Studies Shelley Rabel Reiley (consultant), Minli Xie (Genentech) 1/26/2009 Avantium
Bioanalytical method validation and GLP bioanalysis Danlin Wu (Roche), Mark Rose (Amgen), Patrick Rudewicz (Genentech), Ago Ahene (Roche) 11/24/2008 BRI; Alta, Alturas
Applied Pharmacokinetics George Tonn (Elan), Harvey Wong (Genentech) 10/30/2008 BRI
Overcoming high clearance and poor bioavailability David Lau (J&J); Matthew Wright (Gilead), Tracy Chen (Celgene)  9/10/2008 ABI
Drug metabolism and drug metabolizing enzymes Cyrus Khojasteh (Genentech), Kirk Henne (Amgen), Deepak Dalvie (Pfizer) 6/27/2008 Waters
Drug Transporters Jeff Silverman (Sunesis), Les Benet (UCSF), Kathy Giacommini (UCSF), Joe Ware (Genentech) 4/8/2008 BD
Prediction of in vivo PK profiles from in vitro data Jae Chang, Phil Worboys (Roche) 2/5/2008 BRI 
Drug-drug interaction Magang Shou (Amgen); Simon Wong (Amgen), Adrian Fretland (Roche)  12/11/2007 Phenomenex
in vitro ADME techniques and assays Tim Carlson (Amgen SSF); Bernard Murray (Gilead), Mark Grillo (Amgen)  9/27/2007 ANALIZA
DMPK Regulatory Requirements and Interactions with FDA  Parnian Zia-Amirhosseini (Amgen), Stephen Gracon (Baxter) 8/3/2007 Absorption Systems

 


 

For information and suggestions, click to contact our program chair.


CACO,Last Modified: 11/10/2006 Visited: 78560; Admin Logon